Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 5 47-5, 2003, Pages

  Atkinson, Laura L ^a   Kozak, Ray ^a   Kelly, Sandra E ^a   Onay Besikci, Arzu ^a   Russell, James C ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acetyl CoA carboxylase; AMP activated protein kinase; Glycerol 3 phosphate acyltransferase; Glycolysis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; FATTY ACID; FATTY ACID BINDING PROTEIN; GLUCOSE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; INSULIN; MALONYL COENZYME A; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HEART MUSCLE; INSULIN RESISTANCE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

EID: 0037403420     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00360.2002     Document Type: Article

References (43)

1. Atkinson LL, Kelly SE, Russell JC, Bar-Tana J, and Lopaschuk GD. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR:LA-cp rats. Diabetes 51: 1548-1555, 2002.
2. Awan MM and Saggerson DE. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 295: 61-65, 1993.
3. Beauloye C, Marsin AS, Bertrand L, Krause U, Hardie DG, Vanoverschelde JL, and Hue L. Insulin antagonizes AMPactivated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett 505: 348-352, 2001.
4. Belke DD, Larsen TS, Gibbs EM, and Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279: E1104-E1113, 2000.
5. Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, and Isola LM. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 272: 8830-8835, 1997.
6. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, and Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107: 813-822, 2001.
7. Corr PB, Creer MH, Yamada KA, Saffitz JE, and Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83: 927-936, 1989.
8. Dolphin PJ, Amy RM, and Russell JC. Effect of age on serum lipids and lipoproteins of male and female JCR:LA-corpulent rats. Biochim Biophys Acta 1042: 99-106, 1990.
9. Gamble J and Lopaschuk GD. Insulin inhibition of 5′ adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism 46: 1270-1274, 1997.
10. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 106: 453-458, 2000.
11. Hardie DG and Carling D. The AMP-activated protein kinase: fuel gauge of the manimalian cell? Eur JBiochem 246: 259-273, 1997.
12. Hegarty BD, Cooney GJ, Kraegen EW, and Furler SM. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484, 2002.
13. King MT and Reiss PD. Separation and measurement of short-chain coenzyme-A compounds in rat liver by reversed-phase high-performance liquid chromatography. Anal Biochem 146: 173-179, 1985.
14. Kudo N, Barr AJ, Barr RL, Desai S, and Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
15. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, and Lopaschuk GD. Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996.
16. Lewis GF, Carpentier A, Khosrow A, and Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23: 201-229, 2002.
17. Lopaschuk GD and Barr RL. Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart. Mol Cell Biochem 172: 137-147, 1997.
18. Lopaschuk GD and Russell JC. Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat. J Appl Physiol 71: 1302-1308, 1991.
19. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF, and Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276: 40567-40573, 2001.
20. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, and Hue L. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischemia. Curr Biol 10: 1247-1255, 2000.
21. McGarry JD, Mannaerts GP, and Foster DW. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 60: 265-270, 1977.
22. Morabito D, Montessuit C, Rosenblatt-Velin N, Lerch R, Vallotton MB, and Lang U. Impaired glucose metabolism in the heart of obese Zucker rats after treatment with phorbol ester. Int J Obes Relat Metab Disord 26: 327-334, 2002.
23. Muoio DM, Seefeld K, Witters LA, and Coleman RA. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338: 783-791, 1999.
24. Neely JR and Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of the heart muscle. Ann Rev Physiol 36: 415-439, 1974.
25. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, and Storlein LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
26. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600-1606, 1999.
27. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44: 121-131, 1993.
28. Regan TJ and Weisse AB. Diabetic cardiomyopathy. J Am Coll Cardiol 19: 1165-1166, 1992.
29. Russell JC, Amy RM, Graham SE, Dolphin PJ, Wood GO, and Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta,beta′-tetramethylhexadecanedioic acid (MEDICA 16). Artierioscler Thromb Vasc Biol 15: 918-923, 1995.
30. Russell JC, Dolphin PJ, Graham SE, and Amy RM. Cardioprotective and hypolipidemic effects of nisoldipine in the JCR: LA-cp rat. J Cardiovasc Pharmacol 29: 586-592, 1997.
31. Russell JC, Koeslag DG, Dolphin PJ, and Amy RM. Prevention of myocardial lesions in JCR:LA-cp corpulent rats by nifedipine. Arteriosclerosis 10: 658-664, 1990.
32. Russell JC, Shillabeer G, Bar-Tana J, Lau DCW, Richardson M, Wenzel LM, Graham SE, and Dolphin PJ. Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes 47: 770-778, 1998.
33. Saddik M, Gamble J, Witters LA, and Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268: 25836-25845, 1993.
34. Salt IP, Johnson G, Ashcroft SJ, and Hardie DG. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J 335: 533-539, 1998.
35. Stanley WC, Lopaschuk GD, and McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
36. Swanton EMS and Saggerson ED. Glycerolipid metabolizing enzymes in rat ventricle and in cardiac myocytes. Biochim Biophys Acta 1346: 93-102, 1997.
37. 1H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276: E977-E989, 1999.
38. Winder WW and Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277: E1-E10, 1999.
39. Witters LA and Kemp BE. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5′-AMP-activated protein kinase. J Biol Chem 267: 2864-2867, 1992.
40. Wu-Peng WS, Chua SC Jr, Okada N, Liu SM, Nicolson M, and Leibel RL. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr). Diabetes 46: 513-518, 1997.
41. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, and Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51: 2587-2595, 2002.
42. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, and Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.
43. Zoneraich S and Mollura JL. Diabetes and the heart: state of the art in the 1990s. Can J Cardiol 9: 293-299, 1993.